Ulf Meier-Kriesche
Chief Tech/Sci/R&D Officer bij VELOXIS PHARMACEUTICALS A/S
Profiel
Ulf Meier-Kriesche is currently the Chief Scientific Officer at Veloxis Pharmaceuticals A since 2017.
He obtained a doctorate degree from the University of Perugia.
Actieve functies van Ulf Meier-Kriesche
| Bedrijven | Functie | Begin |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Chief Tech/Sci/R&D Officer | 13-09-2017 |
Opleiding van Ulf Meier-Kriesche
| University of Perugia | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
